ConductScience.org, home

Paper16190825

Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution.

Abe T and 7 others. J Endourol, 2005. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. Papers, record 16190825. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16190825

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution.
PubMed
Journal
J Endourol
PubMed
Year
2005
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
3.8
iCite
Revised in PubMed
2022-03-17
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abe TTaku
2Akakura KKoichiro
3Kawaguchi MMakoto
4Ueda TTakeshi
5Ichikawa TTomohiko
6Ito HHaruo
7Nozumi KKuniyoshi
8Suzuki KKazuhiro

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Kidney CalculiMajor topic
LithotripsyMajor topic
Ureteral CalculiMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multivariate Analysis
Proportional Hazards Models
Recurrence
Risk Factors
Treatment Outcome
Ultrasonography
Urinary Tract
Urography

Source PubMed

Download CSV of topics

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
38696418Stone decision engine accurately predicts stone removal and treatment complications for shock wave lithotripsy and laser ureterorenoscopy patients.PLoS One2024https://conductscience.org/library/papers/38696418PubMed
38250954Assessment of Hounsfield Units and Factors Associated with Fragmentation of Renal Stones by Extracorporeal Shock Wave Lithotripsy: A Computerized Tomography Study.Tomography2024https://conductscience.org/library/papers/38250954PubMed
37032751A nomogram for predicting the risk of residual stone fragments after ureteroscopy.Transl Androl Urol2023https://conductscience.org/library/papers/37032751PubMed
36795174Prospective comparison of extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in patients with non-lower pole kidney stones under the COVID-19 pandemic.Urolithiasis2023https://conductscience.org/library/papers/36795174PubMed
36380209The New Lithotripsy Index predicts success of shock wave lithotripsy.World J Urol2022https://conductscience.org/library/papers/36380209PubMed
35979239Semirigid Ureteroscopy Therapy against Childhood Kidney Stones.Appl Bionics Biomech2022https://conductscience.org/library/papers/35979239PubMed
35670002Clinical application of the therapeutic ultrasound in urologic disease: Part II of therapeutic ultrasound in urology.Investig Clin Urol2022https://conductscience.org/library/papers/35670002PubMed
35439979Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.BMC Urol2022https://conductscience.org/library/papers/35439979PubMed
35293872A Machine Learning Approach to Predict the Outcome of Urinary Calculi Treatment Using Shock Wave Lithotripsy: Model Development and Validation Study.Interact J Med Res2022https://conductscience.org/library/papers/35293872PubMed
34849153Determining whether previous SWL for ureteric stones influences the results of ureteroscopy as the second-line treatment: A clinical study.Exp Ther Med2022https://conductscience.org/library/papers/34849153PubMed
34759642Bilateral same session renal stone surgery tolerance and complications.Urol Ann2021https://conductscience.org/library/papers/34759642PubMed
34540217The effect of stone and patient characteristics in predicting extra-corporal shock wave lithotripsy success rate: A cross sectional study.Ann Med Surg (Lond)2021https://conductscience.org/library/papers/34540217PubMed
34136039Factors influencing extracorporeal shock wave lithotripsy efficiency for optimal patient selection.Wideochir Inne Tech Maloinwazyjne2021https://conductscience.org/library/papers/34136039PubMed
31604986Predicting shockwave lithotripsy outcome for urolithiasis using clinical and stone computed tomography texture analysis variables.Sci Rep2019https://conductscience.org/library/papers/31604986PubMed
30627582Noncontrast Computed Tomography Parameters for Predicting Shock Wave Lithotripsy Outcome in Upper Urinary Tract Stone Cases.Biomed Res Int2018https://conductscience.org/library/papers/30627582PubMed
30488093External physical vibration lithecbole facilitating the expulsion of upper ureteric stones 1.0-2.0 cm after extracorporeal shock wave lithotripsy: a prospective randomized trial.Urolithiasis2020https://conductscience.org/library/papers/30488093PubMed
29896328Factors Affecting the Outcome of Extracorporeal Shockwave Lithotripsy in Urinary Stone Treatment.Oman Med J2018https://conductscience.org/library/papers/29896328PubMed
29719327Role of clinical and radiological parameters in predicting the outcome of shockwave lithotripsy for ureteric stones.Urol Ann2018https://conductscience.org/library/papers/29719327PubMed
29197021
How to accelerate the upper urinary stone discharge after extracorporeal shockwave lithotripsy (ESWL) for < 15 mm upper urinary stones: a prospective multi-center randomized controlled trial about external physical vibration lithecbole (EPVL).
World J Urol2018https://conductscience.org/library/papers/29197021PubMed
28792145Impact of Pretreatment Hydronephrosis on the Success Rate of Shock Wave Lithotripsy in Patients with Ureteral Stone.Yonsei Med J2017https://conductscience.org/library/papers/28792145PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16190825

GET https://conductscience.org/api/papers/v1/16190825/cited_by?page=2